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ABSTRACT
INTRODUCTION:
Lymphadenopathy is a common clinical finding in the Out Patient
Department and may be the sign for various etiology of disease pathology. It is
important to take proper history taking and examination for diagnosing the
etiology of the lymphadenopathy. The etiology varies in different areas.
Tuberculosis is the commonest etiology for cervical lymphadenopathy in India
and African countries. Most of the studies show common benign etiologies as
Non specific reactive lymphadenopathy
METHODS AND METHODOLOGY:
The retrospective and prospective study to analyse study to describe the
etiological causes of lymphadenopathy in patients attending tertiary care centre
among south Indian population.
RESULTS:
Of all patients in this study 46% were males (Mean age 39.1) and 60%
(mean age 29.8). The most common diagnosis was Tuberculosis (62%), Non
Specific lymphadenitis (26%) and Malignancy (12%). Most common site of
Lymphadenopathy is Cervical Lymphadenopathy (83.8%), Sub mandibular
(6.4%), Axillary (6.4%), Supraclavicular (3.2%).
CONCLUSION:
This study concluded most common etiology of lymphadenopathy is
tuberculosis and most commonly affected were females. AFB culture and
sensitivity when compared to GeneXpert had 2.1 times more chances of
detecting TB adenitis. HPE for TB adenitis when compared to GeneXpert had
3.8 times more chances of detecting TB adenitis.
KEY  WORDS:
Lymph node, Tuberculosis, GeneXpert, AFB culture.
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1INTRODUCTION
Body contains about 500 - 560 lymph nodes. Spleen , adenoids, Peyer
patches and tonsils are the lymphatic tissue. The role is to neutralize the antigens
entering into the body from the extra cellular fluid and the environment. Peripheral
lymph nodes are located below the skin and palpable only if any pathological
changes.
“Lymphadenopathy defines as a condition in which nodes are abnormal in
size, texture and count. A lymph node is usually less than 10mm in size. The size
varies in different locations, different ages and different size. An inguinal lymph
node size upto 15 mm is normal. Epi trochlear node upto 5mm is normal. If  the
lymph node size more than 2cm needs clinical evaluation”.
It is important to take proper history taking and examination for diagnosing
the etiology of the lymphadenopathy. The etiology varies in different areas.
Tuberculosis is the commonest etiology for cervical lymphadenopathy in India and
African countries. Most of the studies show common benign etiologies as Non
specific reactive lymphadenopathy
2AIMS & OBJECTIVES
1. To study the etiological causes that cause significant lymphadenopathy in
adults patients referred to tertiary care hospital.
2. To describe the demography of patients referred with significant
lymphadenopathy.
3. To describe the risk factors associated with significant lymphadenopathy.
3REVIEW OF LITERATURE
LYMPH NODE ANATOMY
“These are small oval or reniform bodies (0.1 – 2.5cm long), situated in the
course of lymph vessels so that the lymph passes through them on its way to the
blood. Generally each presents on one side a slight depression, termed as hilum
through which blood vessels enter and leave the node. The efferent lymph vessels
emerges from the node at hilum, afferent vessels enters at different parts of the
periphery. The lymph node has two parts cellular part is called cortex and a darker
medulla containing numerous cavities. These two part has indefinite line of
demarcation”.
4“The cortex does not form the complete investment and its deficient at the
hilum. The medulla reaches the surface of the node hence the efferent vessels are
derived directly from medulla and afferent vessels empties into cortex”.
5The lymph nodes are numerous in the thoracic mediastinum, posterior
abdominal wall, in the abdominal mesenteries, pelvis, neck and proximal ends of
the limbs.
AXILLARY LYMPH NODE:
The main lymphatic drainage of the upper limb is Axillary lymph node
group. The axillary lymph nodes are scattered in the fibro fatty tissue of the axilla.
They are divided into 5 groups
1. Anterior / Pectoral group
2. Posterior /Scapular group
3. Lateral group
4. Central group
5. Apical group
ANTERIOR GROUP:
It lies along the lower border of pectoral minor muscle accompanying lateral
thoracic vessels. These nodes have direct contact with axillary tail of the breast .
They receive lymphatic drainage from
1. Upper half of the anterior wall of  trunk
2. Major part of the breast
6POSTERIOR GROUP:
It lies along the subscapular vessels on the posterior axillary fold. They
receive lymph from
1. Posterior wall of the upper half of the trunk
2. Axillary tail of the breast
LATERAL GROUP:
They lie along the upper part of the humerus medial to the axillary vein.
They receive lymph from the upper limb
CENTRAL GROUP:
It lies on the fat of the upper axilla. They receive lymph from the preceeding
lymph nodes and drain into apical node. They receive some direct vessel rom the
floor of the axilla. It closely related to intercostobrachial nerve.
APICAL GROUP:
It lies deep to the clavipectoral fascia along the axillary vessels. They
receive lymph from
1. Central group
2. Upper part of the breast
3. Thumb and its web space
7The Lymphatic from the thumb accompanies the cephalic vein.
CLINICAL ANATOMY:
Axillary abscess should be incised in the floor of the axilla midway between
the anterior and posterior axillary folds and nearer to the medial wall in order to
avoid injury to the main vessels running along the anterior, posterior and lateral
walls.
8INFRA CLAVICULAR NODES:
Infra clavicular nodes lies on the clavipectoral fascia along the cephalic vein.
They drains upper part of the breast and thumb with its web spaces.
DELTOPECTORAL NODES:
Lies on the deltopectoral group along the cephalic vein. It is the displaced
node of the infraclavicular set and drains upper part of breast and thumb with its
web spaces.
SUPRATROCHLEAR NODE:
Lies just above the medial epicondyle of the humerus along with basilica
vein. It drains  ulnar side of the hand and forearm.
LYMPH NODES OF HEAD AND NECK:
“The entire lymphatic drainage from the head and neck drains into deep
cervical nodes either directly or through the peripheral nodes. The deep cervical
nodes form the vertical chain situated along the entire length of the internal jugular
vein”.
9JUGULO DIGASTRIC NODE:
“It lies below the posterior belly of the digastrics between angle of mandible
and anterior border of sternomastoid in the triangle bounded by posterior belly of
digastric, facial vein and internaL jugular vein. It is the main node draining the
tonsil”.
JUGULO OMOHYOID NODE:
“Lies just above the intermediate tendon of the omohyoid under the cover of
posterior border of sternomastoid. It is the main node draining the tongue”.
LYMPHATIC TRUNK:
“Efferents of the deep cervical lymph nodes join together to form the jugular
lymph trunks one on each side. The left jugular trunk opens into the thoracic duct.
The right trunk may open either into the right lymphatic duct or directly into the
angle of junction between internal jugular and subclavin veins”.
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PERIPHERAL CERVICAL NODES:
The peripheral nodes arranged in two circles.
1. Superficial circle
2. Deep circle
SUPERFICIAL CIRCLE OF CERVICAL LYMPH NODES:
1. Submental
2. Submandibular
3. Buccal and mandibular
4. Preauricular
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5. Postauricular
6. Occipital
7. Anterior cervical
8. Superficial cervical
DEEP CIRCLE OF CERVICAL LYMPH NODES:
1. Pre laryngeal and re tracheal
2. Para tracheal
3. Retropharyngeal
4. Waldeyer’s ring
SUPERFICIAL CIRCLE:
SUBMENTAL NODES:
Lies deep to the chin. Drains lymphatics from tip of the tongue and anterior
part of floor of the mouth
SUBMANDIBULAR NODES:
Drains lateral surface of tongue, lower gum and teeth and central forehead
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BUCCAL AND MANDIBULAR NODES:
“Buccal node lies on the buccinator and mandibular node at the lower of the
mandible near the anteroinferior angle of the masseter in close relation to the
mandibular branch of facial nerve”.
Drains part of the cheek and the lower eyelid. Their efferents pass to the
anterosuperior group of deep cervical nodes.
PREAURICULAR NODES:
Drain parotid gland , temporal region , middle ear
POST AURICULAR NODES:
“Post auricular nodes lies on the mastoid process superficial to
sternomastoid and deep to auricularis posterior”.
Drains strip of scalp just above and below the auricle, upper half of the
medial surface and margin of the auricle and posterior wall of the external acoustic
meatus. They are draining into postero superior group of deep cervical nodes.
OCCIPITAL NODES:
“Lies at the apex of the posterior triangle superficial to the attachment of  the
trapezius. They drain the occipital region of scalp”.
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Their efferents pass to supraclavicular group of postero inferior deep
cervical nodes.
ANTERIOR CERVICAL NODES:
Lies along the anterior jugular vein. They drains the skin of the anterior part
of the neck below the hyoid bone. They drains into deep cervical nodes of both
sides.
SUPERFICIAL CERVICAL NODES:
Lies along the external jugular vein superficial to the sternomastoid muscle.
They drains the lobule of the ear , floor of the external acoustic meatus , the skin
over the lower parotid region and angle of the jaw. They finally drain into upper
and lower deep cervical nodes.
DEEP CIRCLE:
PRE LARYNGEAL AND PRE TRACHEAL NODES:
It lies deep to the investing layer of deep cervical fascia. Pre laryngeal
nodes lies on the cricothyroid membrane. Pre tracheal nodes lies infront of
trachea below the isthmus of thyroid gland.
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They drains larynx, trachea and isthmus of thyroid. They receive afferents
from anterior cervical nodes. They finally drains into deep cervical nodes nearby
PARATRACHEAL NODES:
Lies on the side of the trachea and esophagus along with recurrent laryngeal
nerve. They receive lymphatics from esophagus, trachea and larynx. They finally
drain into deep cervical nodes.
RETROPHARYNGEAL NODES:
Lies infront of the prevertebral fascia and behind the bucco pharyngeal
fascia. They extend laterally infront of the lateral mass of the atlas along with
lateral border of longus capitis muscle.
They drains the pharynx , Eustachian tube , soft palate and posterior part of
the hard palate and nose. They finally drain into upper deep cervical lymph nodes.
WALDEYER’S RING:
It is formed by the following lymphatic structures.
Lingual tonsil
Tubal tonsil
Palatine tonsil
Naso pharyngeal tonsil
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LYMPHATIC DRAINAGE OF LOWER LIMB:
It is classified into superficial and deep system.
SUPERFICIAL SYSTEM:
Superficial inguinal lymph nodes
DEEP SYSTEM:
1. Deep inguinal nodes
2. Popliteal nodes
3. Anterior tibial nodes
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SUPERFICIAL INGUINAL NODES:
It is very important because it drains the skin and fascia of the lower limb,
perineum and the trunk below the umbilicus.
They are divided into three groups.
1. Lower vertical group
2. Upper lateral group
3. Upper medial group
Lower vertical group is placed along with the terminal part of great
saphenous vein. It contains 405 nodes. It drains skin and fascia of the lower limb
and the short saphenous territory except the gluteal region.
Upper lateral group node is situated below the lateral part of inguinal
ligament. It contains about two or three nodes. It drains the skin and fascia of the
upper part of the lateral side of thigh, gluteal region, the flank and back below the
level of umbilicus.
Upper medial group is placed below the medial end of the inguinal ligament.
It contains one or two nodes along with superficial epigastric vessels. It drains
anterior abdominal wall below the level of umbilicus, perineum, genitalia except
glans penis, anal canal below the pectinate line, vagina below the hymen, supero
lateral angle of uterus and penile part of male urethra.
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All superficial inguinal lymph nodes drain into deep inguinal nodes piercing
cribriform fascia. Some may directly drains into external iliac nodes.
DEEP INGUINAL NODES:
It lies medial to the upper part of the femoral vein . it is about 4-5 in number.
The most proximal part of this group of node is called gland of Cloquet or
Rossenmuller.
Rossenmuller lies in the femoral canal.  These nodes receive the lymphatic
drainage from superficial inguinal nodes, popliteal nodes, glans penis or clitoris
and deep lymphatics of the lower limb along with femoral vessels.
They finally drains into external iliac nodes.
POPLITEAL LYMPH NODES:
This group of nodes lies near the termination of short saphenous vein and
deep to deep fascia. They receive lymphatic from territory of the short saphenous
vein, deep part of the legs and knee joint.
Their  efferent run along the popliteal and femoral vessels and terminate in
the deep inguinal nodes.
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ANTERIOR TIBIAL NODES:
It lies along with upper part of anterior tibial artery. It receives lymphatics
from the anterior compartment of the leg
MICROSCOPIC ANATOMY:
A lymph node consists of a continuous framework which includes a capsule,
trabecular and reticular fibres, and the cells entangled in this framework. The
capsule is composed mainly of collagen fibres, a few fibroblasts and some elastin
fibres.
The capsule surrounds the outside of the node and from its deep surface,
trabeculae  of the similar structure extend radially into the inner side of the node,
where they were continue with the reticulum that forms the lymphoid tissue.
The reticulum is the meshwork of fine reticulin fibres and attendant cells
which permeates the spaces outlined by the capsule and trabeculae providing
mechanical support for the cell masses lying in their vicinity.
Lymph nodes are permeated Lymphatic channels  through which the lymph
percolates after it has entered from the afferent lymphatic vessels.
“The arrangement  of lymphatic vessels ensures the maximum exposure of
the lymph to the macrophages and lymphocytes which lines them and are
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entangled between the fibres cross them. The afferent vessels enters at different
points on the periphery of the node”.
“After entering they are branched and forming a dense plexus in the
capsule, open into the subcapsular sinus. From this area numerous radial cortical
sinuses lead towards the medulla, eventually  coalescing to form the larger
20
medullary sinuses which are confluent at the hilum with  the efferent lymphatics or
vessels draining the node”.
These spaces are everywhere lined by endothelial cells and there is a
constant passage of lymphocytes, macrophages and other cells through the sinus
walls in the both directions.
LYMPHATIC BLOOD SYSTEM:
Arteries and veins supply the lymph nodes enter through the hilum and give
off branches which are traverse in the medulla accompanying connective tissue
trabeculae and give off few minor branches
On reaching the cortex arteries divide into arterioles and capillaries which
form numerous anastomosing loops eventually to pass back into the highly
branched venules and veins. The capillaries are profusely around the periphery of
the follicles and fewer in the germinal centre.
Post capillary venules are abundant in the para cortical zones where they are
an important route of lymphocyte migration. The pattern of vascularization is
considerably altered when the node undergo antigenic stimulation to produce large
number of lymphocytes.
The structure of blood vessel is usual except post capillary venules which
are lined by cuboidal endothelial cells. In between the cuboidal endothelial cells
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colloid material pass quite readily into the perivascular space and allows extensive
movement of lymphocytes from the blood stream into the para cortex area of the
lymph node and probably also in the reverse direction.
In addition to the vessels of the nodal medulla some vessels leave the lymph
node through its principal trabeculae and general capsule supplying the
surrounding connective tissues.
Majority of the B and T lymphocytes particularly in the sinuses and around
the germinal centres. The distribution of the lymphocytes is different in the various
parts of lymph node. In the cortex the cells are densely packed and form the
isolated masses called lymphatic follicles (nodules). The number and degree of the
lymphatic follicles vary from time to time according to the level of antigenic
stimulation .
The central part of the each follicle is composed of larger cells and deeply
staining and dividing more rapidly than those at the periphery. The central areas
are called the germinal centre and contains mainly lymphoblasts which are divided
mitotically produce small lymphocytes which are accumulated initially in the
marginal zones around the germinal centre.
“They leave the peripheral part of the follicles to enter the lymphatic sinuses
which convey them through the medulla to the efferent lymph vessel at the hilum
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of the node. In the medulla of the node, the lymphocyte are loosely packed than
they are in the cortex”.
“Under conditions of intense antigenic stimulation, when the node drains a
focus of infection the whole node increases in size and vascularity and called as
reactive node. The number and size of its germinal centre increases with raised
lymphopoiesis, macrophage proliferation and plasma cell differentiation within the
sinuses”.
CELL ZONES IN LYMPH NODES:
Lymph node cortex is divided into number of indistinct lobules by
connective tissue trabeculae passing inwards from the capsule and within these
lobules lies lymphoid follicles. It is divided into 3 zones.
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Zone 1 is a region of loosely packed cells consisting largely of small
lymphocytes ,macrophages and plasma cells.
Zone 2 is more densely packed within zone 1, limited to cortical and para
cortical areas of nodes consisting of mainly small lymphocytes and macrophages.
Zone 3 contains the germinal centres forming the core of the lymphoid
follicles and they are mostly in antigenically stimulated lymph nodes. Zone 3
include large lymphoblasts undergoing mitosis together with macrophages.
Fibroblasts , reticulin fibres and associated cells are scattered throughout all
3 zones.
Non lymphocytic cell types in lymph nodes:
1. Endothelial cells
2. Fibroblasts
3. Macrophages
4. Perivascular cell including pericytes
5. Dendritic cells
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FUNCTIONS OF LYMPHOID SYSTEM:
 Provision of an intricate network of spaces of large volume and surface area
through which lymph circulates slowly.
 Phagocytic action of macrophage
 Trapping of antigens by the phagocytes
 Provisional centre for  lymphocyte production and pool of stem cells
potentially capable of transforming into antibody producing B cells and
mature T cells
 Interaction between antigen laden phagocyte and lymphocyte to mount an
immune response both cellular and humoral
 Portal entry of blood borne lymphocytes back into the lymphatic sinus
 Humoral antibody production
25
EMBRYOLOGY:
Initial stage of development of lymphatic system according to two views. –
First view (Huntington 1908; McClure and Bulter 1925), lymphatic spaces
commences as clefts in the mesenchyme and lined by endothelium. These spaces
forms capillary plexus from which lymph sacs are derived.
Second view (Sabin 1902) – the earliest lymph vessels arise as a capillary
off shoot from the endothelium of the veins and which form capillary plexus; later
these plexus lose their connections with the venous system and become confluent
to form lymph sacs.
In human embryo lymph sacs from which lymph vessels are derived are six
in number.
- Two paired – (jugular and posterior lymph sac )
- Two unpaired – (Retroperitoneal and cistern chyli)
The position of the sacs as follows
1. Jugular – first appear , at the junction of subclavian and precardinal
vein
2. Posterior sac – at the junction of the iliac vein with the postcardinal
vein
3. Retroperitoneal – at the root of  the mesentry near suprarenal glands
4. Cistern chyli – opposite to the third and fourth lumbar vertebra
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The lymph vessels are budding out from the lymph sacs along the lines of
corresponding course of the embryonic vessels. The thoracic duct is
phylogenetically bilateral structure. Numerous valves are lied down the duct
during the fifth month of intra uterine life but many of them disappear before birth.
All lymphatic sacs except the cistern chili are divided into numerous slender
connective tissue bridges at the later stages. Lymph sacs are invaded by
lymphocytes and are transformed into groups of lymph node. The lymph sinuses
representing the portions of the original cavity of the sac.
Haemel lymph nodes are said to develop as mesenchymal condensation in
close relation to blood vessels rather than lymphatics.
27
HISTOLOGY
Section shows cortex , capsule ,germinal centre , secondary cortical nodules ,
medullary cords and medullary sinus.
28
Section shows medulla , septal blood vessels , Hassall bodies and
lymphocytes.
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CLASSIFICATION OF  MYCOBACTERIA:
TUBERCLE BACILLI Human – M.tuberculosis
Bovine – M.bovis
Murine – M.microti
Avian – M.avian
Cold blooded – M.marinum
LEPRA BACILLI Human – M.leprae
Murine – M.leprae murium
MYCOBACTERIA CAUSING
SKIN ULCER
M.ulcerans
M.balnei
ATYPICAL
MYCOBACTERIA
Photo chromogens
Scoto chromogens
Non photo chromogens
Rapid growers
JOHNE’S BACILLI M.paratuberculosis
SAPROPHYTIC
MYCOBACTERIA
M.butyricum
M.phlei
M.stercoris
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MYCOBACTERIA:
Mycobacteria means fungus like bacteria. They do not stain readily. Resist
discolouration with dilute mineral acids and hence called as ‘Acid fast
bacilli’.They are aerobic, non motile, non capsulated and non sporing.
First member of this genus was identified was lepra bacilli, discovered by
Hansen in 1868. Koch’s (1882) isolated a mammalian tubercle bacilli and proved it
causative role  in tuberculosis by satisfying Koch’s postulates.
MYCOBACTERIA TUBERCULOSIS
MORPHOLOGY:
It is straight or slightly curved rod measuring about 3 microns , occurring
singly or pairs or as small clumps. The size depends on conditions of growth and
long filamentous, club shaped and branching forms may be seen.
When stained with carbol fushin by ziehl neelson method or by fluorescence
dyes, they resist decolourisation by 20% sulphuric acid and absolute alcohol for 10
minutes.
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CULTURE CHARACTERISTICS:
The colonies grow slowly; generation time in vitro about 14-15 hours;
Growth appears in about two weeks and may sometimes takes upto eight weeks.
Optimum temperature is 37-400C . Optimum pH is 6.4-7.0. It is an obligate
aerobe. It grows luxuriantly in culture and termed as eugenic. The addition of 0.5%
glycerol improves the growth of M.tuberculosis.
Human tubercle bacilli does not grow in the presence of P-nitrobenzoic acid
.They do not have exacting growth requirements but are highly susceptible even to
traces of toxic substances like fatty acids in culture media.
The toxicity is neutralized by serum albumin or charcoal.
SOLID MEDIA LIQUID MEDIA
LJ medium
Petragnini
Dorset egg
Tarshis
Loeffler Serum
Pawlowsky
Dubos
Middlebrook
Proskauer
Beck
Sula’s and Sauton
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Liquid medias are usually not used for the cultivation but are used sensitivity
testing, chemical analysis and preparation of antigens and vaccines.
On solid media M. tuberculosis forms dry, rough, raised, irregular colonies
with a wrinkled surface. They are creamy white, becoming yellowish or buff
coloured on further incubation. They are tenacious and not easily emulsified.
In liquid media without dispersing agents the growth begins at the bottom,
creeps up the sides and forms a prominent surface pellicle which may extend along
sides above the medium. Diffuse growth is obtained in Dubos medium containing
Tween – 80.
BIO CHEMICAL REACTIONS:
Several tests has been described for identification of Mycobacterium species.
1. Niacin test
2. Aryl sulphatase test
3. Neutral red test
4. Catalase –peroxidase test
5. Amidase tests
6. Nitrate reduction test
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PATHOGENESIS:
“In un-exposed, immunocompetant person CMI against Mycobacterium,
results in immunity to infection to the bacteria and develop hypersensitivity to
mycobacterial antigens. The histologic presentation of tuberculosis show caseating
granulomas and then cavitation. These are the manifest of the hypersensitivity that
develops in concordance with the host immune protection”.
“The effector cells that mediate immune protection also contribute to
hypersensitivity and so results in tissue destruction. Appearance of hypersensitivity
in tuberculin skin test show immunity to infection of the organism”.
Macrophages are the main cells infected by M. tuberculosis. Tuberculosis
bacilli replicate essentially unchecked initially. Later the CMI stimulates
macrophages to stop the proliferation of the bacteria.
M. tuberculosis enters macrophages by endocytosis by the following
1) mannose receptors bind lipoarabinomannan
2) a glycolipid in the bacterial cell wall and
3) complement receptors bind opsonized mycobacteria
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“Tuberculosis organisms replicate within the phagosome by inhibiting
fusion of the phagosome and lysosome. Tuberculosis inhibits phagolysosome
formation by blocking Ca2+ signals and recruit the macrophages secrete group of
proteins that mediate phagosome-lysosome fusion. In the earliest stage of primary
tuberculosis (<3 weeks) in the nonsensitized persons, bacteria multiply in the
pulmonary alveolar macrophages and airspaces, causing bacteremia and
disseminating the mycobacterium to many sites. Asymptomatic to mild febrile
illness is the presentation”.
The genetic component of the individual may alter the course of the
tuberculosis. Polymorphisms in the NRAMP1 gene, results in progress of the
disease due to the absence of immune response. NRAMP1 is a transmembrane
protein in endosomes and lysosomes that pushes the divalent cations out of the
lysosome. NRAMP1 may block microbial growth by reducing availability of ions
for the bacteria.
“After 21 days of infection, a T-helper 1 (TH1) action is mounted to kill the
mycobacterium. The mycobacterial antigens that enter draining lymph nodes
stimulates the T cells. Differentiation of TH1 cells depends on IL-12, which is
produced by antigen-presenting cells that have encountered the mycobacteria. M.
tuberculosis secretes ligands for TLR2, and initiation of TLR2 by these ligands
results in production of IL-12 by dendritic cells”.
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“TH1 cells, in lymph nodes and in the lung, release IFN-γ. INF-γ is the
mediator that enables macrophages to inhibit the M. tuberculosis. IFN-γ stimulates
phagolysosome in infected macrophages, exposing the bacteria to acidic
environment. IFN-γ also stimulates nitric oxide synthase, which produces nitric
oxide, capable of neutralizing mycobacterium cell wall”.
“The TH1 response results in the formation of granulomas with caseous
necrosis. Macrophages differentiate into the “epithelioid histiocytes” by activated
by IFN-γ that result in the granulomas and fuse to form giant cells. In most cases
this halts the infection before tissue destruction or illness. In some the infection
progresses due to old age or immunosuppression, and ongoing immune response
results in tissue destruction due to caseation and cavitation. Macrophages also
produce TNF, which promotes more monocytes”.
“NK-T cells recognize mycobacterial lipid antigens attached to CD1 on
antigen-presenting cells, or T cells that show a γδ T-cell receptor, also form IFN-γ.
TH1 cells have a central role in this process. Defects in any of the steps in forming
TH1 response result in disease worsening state”.
In summary, immunity to M. tuberculosis is primarily mediated by TH1 cells,
which stimulate macrophages to kill the bacteria. This immune response, while
largely effective, comes at the cost of hypersensitivity and accompanying tissue
destruction. Reactivation of the infection or re-exposure to the bacilli in a
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previously sensitized host results in rapid mobilization of a defensive reaction but
also increased tissue necrosis. Just as hypersensitivity and resistance are correlated,
so, too, the loss of hypersensitivity (indicated by tuberculin negativity in a
previously tuberculin-positive individual) may be an ominous sign that resistance
to the organism has faded
Tubercle granuloma at histology
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“Tubercle at low magnification (A) and in detail (B) show central caseation with a
ring of epithelioid along with multinucleated giant cells. This is the normal
response in patients with cell-mediated immunity to the organism. Not all
tubercular granulomas might have central caseation (C); hence, special stains for
AFB must be done when granulomas are seen. In immune-compromised without
cellular immunity layers of fatty macrophages are seen that are filled with
mycobacteria (demonstrable with AFB stains)”.
EPIDEMIOLOGY:
In India and tropical countries TB is the commonest cause for
lymphadenopathy in adults. Next is malignancy. In patients with HIV in recent
days increased incidence of extra pulmonary TB is associated with more than 50%.
In general less than 1% of patients having lymphadenopathy is due to
malignant diseases. In children leukemia , in adolescents often due due Hodgkin
disease.
Hodgkin disease is common after 10 years of age and male more affected in
childhood. The combination with HIV , EBV infection is increased risk for
Hodgkin’s disease in economically poor countries and low socio economic status.
In worldwide NHL is the 4th common malignancy in males.
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HISTORY TAKING:
History taking is necessary to determine the cause of lymphadenopathy.
Age, sex, onset, duration of symptoms, underlying co morbidities are
important. In addition history of exposure to pets, ingestion of drugs and foods,
history of recurrent infection and immunodeficiency contributes to the diagnosis.
Chewing of tobacco, smoking, alcohol and UV radiation increases the risk of
the metastatic malignancies of head & neck and organs. Immune deficient
individuals like HIV positive can have Kaposis sarcoma and Non Hodgkin
lymphoma.
Family history of malignancy can raise the suspicion of Breast carcinoma,
melanoma and dysplastic nevus syndrome. Lymphadenopathy lasting less than 1
month to 12 months without increase in size have less chances to be a malignant.
SIGNS AND SYMPTOMS:
MONO NUCLEOSIS LIKE SYMPTOMS:
High fever
Pharyngitis
Tender lymphadenopathy
Splenomegaly
39
All above are present in Infectious mononucleosis and also in CMV
infection, Toxoplasmosis, HIV, HHV type I .In HIV generalized
lymphadenopathy is seen after 2-6 weeks of exposure to HIV virus.
History of travel to an endemic area or contact with TB infected persons
may lead to painless progressive gradually increase in size of lymphadenopathy.
The lymph node may be single or matted. It may be suggestive of tuberculosis
infection.
Lymphadenopathy associated with arthralgia , muscle weakness , rashes and
anemia suggestive of auto immune diseases like Rheumatoid arthritis, SLE etc.
B symptoms :
Fever
Night sweats
Weight loss more than 10% in 6 months
Suggestive of lymphoproliferative malignant disorders. Generalized pruritis,
painful lymphadenopathy following alcohol intake may suggestive of Hodgkin
disease. Petechiae , purpura, lymphadenopathy and splenomegaly may present in
acute leukemias.
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EXAMINATION OF LYMPHADENOPATHY:
All patients of lymphadenopathy must be examined thoroughly.
Examination of lymph nodes for its location, size, consistency and tenderness is
important.
LOCATION:
1. Generalized
2. Localized
3. Presence of red lymphangitic streaks
4. Supra clavicular area is high risk for malignancy
SIZE:
Palpable lymphadenopathy of  more than 0.5 cm in supraclavicular,
epitrochlear, cervical, popliteal and iliac nodes ; and inguinal node of more than
1.5 cm is suggestive of pathological
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PAIN AND TENDERNESS:
It may be due to infection and also induced by hemorrhage in the neoplastic nodes
or rapid tumour expansion.
CONSISTENCY:
Chronic inflammation leads to fibrosis make the node hard in palpation.
Acute inflammation due to tension on the capsule causes tenderness.
Stony hard and painless node is usually metastatic or granuloma of lymph node.
Firm and rubbery nodes are seen in lymphoma. Matted lymph nodes are seen
in mycobacterium infection.
MOBILITY:
Lymphadenopathy due to infections and collagen vascular diseases are
freely mobile in subcutaneous plane. Rubbery mobile nodes usually suggestive of
lymphoma. Hard fixed node is usually due to metastatic and malignancy diseases.
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ASSOCIATED SYMPTOMS:
Splenomegaly associated with lymphadenopathy seen in infectious mono
nucleosis, acute lymphoma, Hodgkin disease , NHL  and sarcoidosis.
Skin lesions are common in malignancies such as melanoma. Traumatic lesions
can be the cause for axillary lymphanopathy by the infections in the draining area.
The benign reactive inguinal lyphadenopathy seen in bare foot walkers.
Localized lymphadenopathy is typical of infections and due to sexually transmitted
diseases like HSV ,Gonococcal infection, syphilis, LGV ,and Granuloma inguinale
Malignancy is rare when only inguinal nodes are enlarged. Carcinoma of
penis, vulva and anus can involve inguinal lymphadenopathy.
PERIPHERAL LYMPHADENOPATHY – DIFFERENTIAL DIAGNOSIS:
LOCALISED PERIPHERAL LYMPHADENOPATHY:
Cervical Viral: URI, Infectious mononucleosis,
Human herpes virus/ CMV/ HIV,
Coxsackie virus
Bacterial: staphylococccus aureus,
Streptococcal pyogenes (Gr A),
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Mycobacterium
Malignancy: Hodgkin, NHL, CA
thyroid, metastatic carcinoma.
Supraclavicular Abdominal and thoracic malignancy
CA breast,
Mycobacterial and fungal infections
Axillary Bacterial: Staphylococccus aureus,
Streptococcal pyogenes (Gr A),
Mycobacterium
Malignancy : Lymphoma, Leukemia
Inguinal Benign reactive lymphadenopathy
STD infections
Lymphoma, carcinoma of penis and
vulva, metastatic melanoma
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GENERALISED PERIPHERAL LYMPHADENOPATHY:
Infections Infectious mononucleosis, HIV,
Miliary TB, Typhoid fever, syphilis,
Plague
Malignancy Lymphoma and AML
Auto immune disorders SLE, RA, Sjogren syndrome,
Sarcoidosis
Drug reactions Phenytoin, Allopurinol, Atenolol
Lipid storage diseases Gaucher’s  & Niemann Pick disease
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LABORATORY DIAGNOSIS:
1. Complete hemogram
2. Viral markers – HIV, HBV, HCV, CMV
3. Anti nuclear antibody
4. ESR
5. Mono spot test
6. VDRL
7. Mantoux test
8. Peripheral smear
9. Imaging – Colour Doppler USG, CT scan and MRI scan
10.Chest X Ray
11.FNAC (USG guided)
12.Gram staining and special staining of FNAC of lymph nodes
13.Sputum AFB and C/S
14. GeneXpert analysis
15.TB C/S
16.Histopathological examination
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GENEXPERT:
The Xpert MTB/RIF detects DNA sequences specific for Mycobacterium
tuberculosis and rifampicin resistance by polymerase chain reaction.It is based on
the Cepheid GeneXpert system.it is a rapid and simple-to-use nucleic acid
amplification tests (NAAT). The Xpert MTB/RIF purifies and
concentrates Mycobacterium tuberculosis bacilli from sputum samples, isolates
genomic material from the captured bacteria by sonication and subsequently
amplifies the genomic DNA by PCR.
The process identifies all the clinically relevant Rifampicin resistance
inducing mutations in the RNA polymerase beta (rpoB) gene in
the Mycobacterium tuberculosis genome in a real time format using fluorescent
probes called molecular beacons. Results are obtained from unprocessed sputum
samples in 90 minutes, with minimal biohazard and very little technical training
required to operate.
A review to assess the diagnostic accuracy of Xpert TB found that when used
as an initial test to replace smear microscopy it had pooled sensitivity of 88% and
specificity of 98% . However when Xpert TB was used as an add-on for cases of
negative smear microscopy the sensitivity was only 67% and specificity 98%.
In a clinical study conducted the sensitivity of the MTB/RIF test on just 1
sputum sample was 92.2% for culture-positive TB; 98.2% for smear- and culture-
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positive cases; and 72.5% for smear-negative, culture-positive cases, with a
specificity of 99.2%. Sensitivity and higher specificity were slightly higher when 3
samples were tested
New TB tests are needed because of the difficulties associated with the tests
that are currently used both to diagnose TB as well as to detect drug resistance.
Traditionally TB has been diagnosed by looking for evidence of TB bacteria
either through the use of the chest X-ray, through sputum smear microscopy, or
through the culturing of bacteria. Each of these TB tests has their disadvantages,
one of the most significant for culture being the time that it takes and for sputum
the matter of accuracy.
In addition to diagnosing TB there is also a need to test for drug resistance,
in order that the most effective TB treatment can be provided. Culture is currently
the main tool for drug susceptibility testing. However, not only is the length of
time it takes a problem, but it also requires trained personnel and expensive
laboratory equipment.
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The Xpert MTB/RIF has been developed by the Foundation for Innovative
New Diagnostics (FIND), who have partnered with the Cepheid corporation and
the University of Medicine and Dentistry of New Jersey. Some of the funding for
the development of the Xpert MTB/RIF was provided by the NIH
WHO recommended that the test should be used as the initial diagnosis test
in individuals suspected of having MDR TB, or HIV associated TB. They also
suggested that it could be used as a follow on test to microscopy in settings where
MDR TB and/or HIV is of lesser concern, especially in smear negative specimens,
because of the lack of accuracy of smear microscopy. They did however say that
they recognised the major resource implications of using it in this second way.
WHO did also emphasize that the test does not eliminate the need for
conventional microscopy culture and drug sensitivity testing, as these are still
required to monitor treatment progress and to detect other types of drug resistance.
The Xpert MTB/RIF cannot be used for treatment monitoring, as it detects
both live and dead bacteria.Further guidance was subsequently provided by WHO
on the rapid implementation of the new test
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Disadvantages
There are a number of disadvantages which include:
 The shelf life of the cartridges is only 18 months;
 A very stable electricity supply is required;
 The instrument needs to be recalibrated annually;
 The cost of the test;
 The temperature ceiling is critical.
Advantages
The main advantages of the test are, for diagnosis, reliability when compared
to sputum microscopy and the speed of getting the result when compared with
culture. For diagnosis of TB, although sputum microscopy is both quick and cheap,
it is often unreliable.
It is particularly unreliable when people are HIV positive. Although culture
gives a definitive diagnosis, to get the result usually takes weeks rather than the
hours of the Xpert test.The main advantage in respect of identifying rifampicin
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resistance, is again the matter of speed. Normally to get any drug resistance result
takes weeks rather than hours.
FALGON TUBE:
Suitable for cell centrifugation applications such as pelleting and separation by
density gradients; molecular biology applications including concentrating bacteria
for DNA isolation, purification and precipitation of nucleic acids, sample storage
(ambient temperature from -4 to +60°C) and centrifugation of precipitates.
 Dark blue graduations in 0.5mL increments are visible with clear or turbid
samples
 Solvent-resistant white writing area
 Sterilized by gamma irradiation, nonpyrogenic
 Supplied blue HDPE 20mm threaded dome seal closures provide positive
seal over the full circumference
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Clarified Polypropylene
 Resistant to alcohols and mild organic solvents (not recommended for
extraction procedures)
 Translucent wall for easy viewing
 Stable from -4° to +60°C (24.8° to 140°F)
 (Withstand centrifugal forces to 12,000 x g RCF
Polystyrene
 Optically clear for easy viewing of sample
 Stable from 4° to 60°C (39° to 140°F)
 Withstand centrifugal forces up to 1800 x g RCF
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CULTURE MEDIA:
“The definite diagnosis of tuberculosis demands that M.tuberculosis be
recovered on culture media and identified using differential in vitro tests. Many
different media have been devised for cultivating tubercle bacilli and three main
groups can be identified, viz egg-based media, agar-based media and liquid
media.”
“The ideal medium for isolation of tubercle bacilli should (a) be economical
and simple to prepare from readily available ingredients, (b) inhibit the growth of
contaminants, (c) support luxuriant growth of small numbers of bacilli and (d)
permit preliminary differentiation of isolates on the basis of colony morphology.”
“For the culture of sputum specimens, egg-based media are the first choice,
since they meet all these requirements.”
PREPARATION OF LOWENSTEIN-JENSEN MEDIUM:
“Lowenstein-Jensen (LJ) medium is most widely used for tuberculosis
culture. LJ medium containing glycerol favours the growth of M.tuberculosis while
LJ medium without glycerol but containing pyruvate encourages the growth of M.
bovis.”
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“Ingredients:”
“Mineral salt solution with malachite green
Potassium dihydrogen phosphate anhydrous (KH2PO4)    2.4g
Magnesium sulphate anhydrous 0.24g
Magnesium citrate 0.6g
Asparagine 3.6g
Glycerol (reagent grade) 12ml
Malachite green, 2% solution 20ml
Malachite green solution 2%
Malachite green dye 2.0g
Distilled water 100ml”
“Dissolve the dye in distilled water completely. Filter and store in
refrigerator.Dissolve the ingredients in order in about 300ml distilled water by
heating. Add glycerol, malachite green solution and make up 600ml with distilled
water.”
“This solution should be sterilized by autoclaving at 121o C (15 psi) for 30
minutes. Cool to room temperature. If required, this solution may be stored in the
refrigerator.”
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“Homogenised whole eggs :Fresh country hen’s eggs those are not more
than seven days old, are cleaned by scrubbing thoroughly with a hand brush in
water and soap. Let the eggs soak for 30 minutes in soap solution. Rinse eggs
thoroughly in running water and soak them in 70% ethanol for 15 minutes. Before
handling the clean dry eggs scrub and wash the hands with a disinfectant. Crack
the eggs with the edge of the beaker into a sterile flask and beat them in a sterile
blender for 30 seconds to one minute.”
“Preparation of complete medium:
The following ingredients are aseptically pooled in a large, sterile flask and
mixed well:
Mineral salt solution with malachite green 600ml
Homogenised eggs (25-30 eggs, depending on size) 1000ml
The complete egg medium is distributed in 6-8ml volumes in sterile
universal containers and the caps tightly closed and inspissated without delay to
prevent sedimentation of heavier ingredients.”
“Coagulation of medium:
Before loading, heat the inspissator to 85o C to quicken the build-up of the
temperature. Place the bottles in a slanted position in the inspissator and coagulate
the medium for 50 minutes at 85o C (since the medium has been prepared with
sterile precautions this heating is to solidify the medium, not to sterilise it.”
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“The quality of egg media deteriorates when coagulation is done at too high
a temperature or for too long. Discolouration of the coagulated medium may be
due to excessive temperature. The appearance of little holes or bubbles on the
surface of the medium also indicates faulty coagulation procedures.”
“Sterility check:”
“After inspissation, the whole media batch of the media bottles should be
incubated at 350 C- 370C for 24 hours as a check for bacterial sterility. After 24
hours 5% of the slopes should picked up randomly and continued for incubation
for 14 days to check for fungal sterility. In both the cases the contamination rate
should not be > 10 %.”
“Storage:”
“The LJ medium should be dated and stored with the batch number in the
refrigerator and can keep for upto 4 weeks if the caps are tightly closed to prevent
drying of the medium.”
Note :
• “Prepare one batch of plain LJ media one week before the anticipated arrival of
samples (one batch is 1620 ml of LJ fluid sufficient for 324 LJ slopes). The
requirement is two LJ slopes for each specimen.”
“One batch of media provides 20 sets for drug susceptibility testing and an
additional 44 plain LJ slopes. One set of drug susceptibility testing media consists
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of 5 plain LJ slopes, 2 slopes each for four drugs and one PNB containing LJ
media.”
“In the initial period, it is recommended not to prepare more than one batch of
media per day.”
“L-J Medium with sodium pyruvate:”
“For the cultivation of M. bovis, LJ medium is enriched with 0.5% sodium
pyruvate. In the preparation of the mineral salt solution, glycerol is omitted and
8.0g sodium pyruvate is added for every 600 ml. This is added to 1 litre of egg
fluid, mixed well and distributed.”
“DRUG SUSCEPTIBILITY TESTS :”
“Drug susceptibility testing is one of the most difficult procedures to
perform and standardize in the mycobacteriology laboratory. Proficiency in
susceptibility tests demands an understanding of:”
“• The origin of drug resistance
• The variation in stability of drugs subjected to different conditions of
filtration, heat or storage
• The alteration in the activity of certain drugs when incorporated into
different kinds of media
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• The type of susceptibility test performed
• The reading and reporting of test results
• The criteria of resistance .”
“Drug susceptibility tests should be performed in the following instances:
• For relapse or re-treatment cases
• To change the drug regimen when drug resistance is suspected
• Undertaking drug resistance surveillance studies in a region/country.”
“There are three general methods used for determining drug susceptibility of
mycobacterium: the proportion method, absolute concentration method (MIC
method) and the resistance ratio method, and When properly standardized and
performed, all three methods have been shown to be equally satisfactory.”
“In India, under RNTCP, proportion method is advised since large numbers
of laboratories have standardized this method for DST.”
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METHODS :
“THE PROPORTION METHOD:”
“It enables precise estimation of the proportion of mutants resistant to a
given drug. Several 10-fold dilutions of inoculum are planted on to both control
and drug –containing media; at least one dilution should yield isolated countable
(50 -100) colonies.”
“When these numbers are corrected by multiplying by the dilution of
inoculum used, the total number of viable colonies observed on the control
medium, and the number of mutant colonies resistant to the drug concentrations
tested may be determined. The proportion of bacilli resistant to a given drug is then
determined by expressing the resistant portion as a percentage of the total
population tested.”
“THE ABSOLUTE CONCENTRATION METHOD:”
“This method uses a standardized inoculum grown on drug-free media and
media containing graded concentrations of the drug(s) to be tested. Several
concentrations of each drug are tested, and resistance is expressed in terms of the
lowest concentration of the drug that inhibits growth; i.e., minimal inhibitory
concentration (MIC). This method is greatly affected by inoculum size and the
viability of the organisms.”
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“THE RESISTANCE RATIO METHOD:”
“It compares the resistance of unknown strains of tubercle bacilli with that
of a standard laboratory strain. Parallel sets of media, containing twofold dilutions
of the drug, are inoculated with a standard inoculum prepared from both the
unknown and standard strains of tubercle bacilli. Resistance is expressed as the
ratio of the minimal inhibitory concentration (MIC) of the test strain divided by the
MIC for the standard strain in the same set.”
“The proportion method is currently the method of choice and the simple
version of bacterial suspension and interpretation of results are given below.”
“The economic variant of proportion method used under RNTCP.”
“PROCEDURE DETAILS FOR THE PROPORTION METHOD
STANDARD ECONOMIC VARIANT BACTERIAL SUSPENSION:”
“Inoculum:”
“With a loop, a representative sample of approximately 4-5 mg is taken from
the primary culture and placed in a McCartney bottle containing 1 ml sterile
distilled water(SDW) and 6 glass beads of diameter 3 mm. The bottle is vortexed
for 20–30 seconds; 4-5 ml of distilled water is added slowly under continuous
shaking.”
61
“Allow the coarse particles to settle down. Decant the mycobacteria
carefully into another clear, sterile McCartney bottle. The opacity of the bacterial
suspension is then adjusted by the addition of distilled water to obtain a
concentration of 1 mg/ml of tubercle bacilli by matching with McFarland standard
No.1”
“Preparation of suspensions for economic variant of proportion method:”
“1 ml SDW with six 3 mm glass beads + 1 loopfull (3 mm internal diameter) of
culture vortexed for 20 – 30 seconds
↓
Add 4 ml of SDW to the above
↓
Adjusted turbidity with McFarland 0.05 with SDW.
↓
S2-10 –2 2 loopfull of neat + 2ml of SDW
↓
S4-10-4 2 loopful of S2 + 2ml of SDW”
62
“Precautions:”
“- Avoid touching the media while picking the colonies,
- Cool down the loop sufficiently before picking the colonies,
- Try to take loopful of colonies in one sweep, by touching all colonies on the LJ
slope.
- Avoid touching the water of condensation while scrapping the colonies
- Emulsify the initial inoculums onto the walls of the McCartney bottle”
“PREPARATION OF MC FARLAN NEPHELOMETER BARIUM SULFATE
STANDARD No.1 (Paik, G. 1980)”
“1. Prepare 1% aqueous barium chloride and 1% sulphuric acid (AR)
solutions. (100 mg of Barium chloride (anhydrous) in 10 ml of SDW and 0.1 ml of
sulphuric acid (AR) in 10 ml of SDW).
2. Add 0.1 ml of 1% Barium Chloride to 9.9 ml of 1% Sulphuric acid to
obtain the McFarland standard No.1, which matches with 1 mg/ ml of M.
tuberculosis.
3. Seal the tube with parafilm and label as McFarland standard No.1 with
date of preparation.”
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“During preparation of neat bacterial suspension, the comparison is done
against a white background. After preparing the standard Neat suspension, either a
loop or pipettes may be used for further processing and for inoculation. It is
recommended to use loop method under RNTCP.”
“ Inoculation for DST – Loop method”
“The loop should be of Nichrome wire (24 SWG) and should have an
internal diameter of 3 mm, which delivers 0.01 ml. Delivery volume must be
verified by weighing 10 loopfuls of distilled water deposited on a filter paper.”
“The two bacterial dilutions required for inoculation with the loop are 10–2
and 10–4 from the neat prepared as above. The dilutions 10-2 is produced by
discharging two loopfuls of the bacterial suspension, standardized at 1 mg/ml, into
a Bijou bottle containing 2 ml of distilled water. Mix the contents by shaking.”
“Similarly, the dilution 10–4 is produced by discharging two loopfuls of the
10–2 dilution into a small tube containing 2 ml of distilled water. Mix the contents
by shaking. Two slopes of medium without drug and one slope of medium with
drug for each of the four drugs are inoculated with a loopful of each dilution.”
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“Precautions:”
“Avoid touching the water of condensation while inoculation. Don’t allow
water condensation to spread over the media surface
- Inoculate uniform suspension in all the slopes
The standard strain M. tuberculosis, H37Rv is tested with each new batch of
medium. The recommended drug concentrations are 4 mg/l for streptomycin, 0.2
mg/l for isoniazid, 40 mg/l for rifampicin and 2 mg/l for ethambutol.”
“ Additional recommendation:”
“The inoculum indicated above usually provides satisfactory countable
colonies for the test, i.e., more than 10 and less than 100 colonies per control slope
seeded with smaller inoculum. However, in some laboratories, the yield may prove
smaller, owing to different growth conditions. In such cases, initially, the labs
should seed 10-2, 10-3 and 10-4 dilutions.”
“INCUBATION AND READING”
“Incubate the slopes at 37oC.
Read the proportion tests at 28 days and again at 42 days.”
“Record growth as
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3+ Confluent growth
2+ More than 100 colonies
1-99 cols Actual number of colonies
“When the number of colonies on a given dilution is less than 15, count the
number of colonies with the next larger inoculum, or estimate if more than 100.
(Make no attempt to estimate the number of colonies if the growth is 3+)”
“INTERPRETATION OF TESTS:”
“1. First reading is taken at 28th day after inoculation.
2. Count the colonies only on the slopes seeded with the inoculum that has
produced exact readable counts or actual counts (up to 100 colonies on the slope).
This inoculum may be the same for the control slopes and the drug-containing
slopes, or it may be the low inoculum (10–4 dilution) for the control slopes and the
high inoculum (10–2 dilution) for the drug-containing slopes.
3. The average number of colonies obtained for the drug-containing slopes
indicates the number of resistant bacilli contained in the inoculum.
4. Dividing the number of colonies in drug containing slopes by that in drug free
slopes gives the proportion of resistant bacilli existing in the strain. Below a certain
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value – the critical proportion – the strain is classified as sensitive; above that
value, it is classified as resistant. The proportions are reported as percentages.
5. If, according to the criteria indicated below, the result of the reading made on
the 28th day is “resistant”, no further reading of the test for that drug is required:
the strain is classified as resistant. If the result at the 28th day is “sensitive”, a
second reading is made on the 42nd day only for the sensitive strain. The final
definitive results for all the four drugs should be reported on 42nd day. If the strain
is resistant for all the four drugs on 28th day, then the report can be given on the
same day. Otherwise, incomplete reports should not be given before 42nd day.
6. In case growth on the control media is poor even after six weeks (i.e., few or no
colonies on the 10-4 bacterial dilution), the test should be repeated.
7. Repeat the test: Test showing an average of less than 10 colonies in the control
slopes seeded with the smaller inoculum.”
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MATERIALS AND METHODS
 All Patients who fit with the inclusion criteria and give consent will undergo
the test.
 Demographic details collected.
 Anaesthetist fitness.
 Risk consent.
 GA/RA/LA
 Gene X PERT in Falgon test tube
 Biospy – one in formalin for HPE and another in sterile container for AFB
culture.
 Results tabulated and studied.
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SUBJECT SELECTION
INCLUSION CRITERIA:
 Age > 18 yrs
 Patient should have significant lymphadenopathy which is described as
 Size: Insignificant if < 2cm
 In axilla and inguinal, insignificant if < 3cm
 In the supraclaviclar fossa > 1cm is significant
 Consistency: soft (insignificant), rubbery (classically lymphoma) , hard
(classically malignancy & granulomatous infection).
 Tender (classically infection) vs. non-tender (classically malignancy)
EXCLUSION CRITERIA:
 Age < 18 yrs
 Any seriously ill patient
 Unfit for anaesthesia
 Patient 2-12 years old commonly present with insignificant lymph nodes in
neck secondary to frequent viral infection.
Study period : December 2014 –AUGUST 2015
Sample size : 50
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Study design : Prospective and Retrospective
Study procedures :
All eligible patients were informed about the study procedures in detail.
Informed consent was obtained from willing patients. After getting anaesthetist
fitness, biopsy of the concerned lymph node was done. The sample was sent for
three investigational procedures namely geneXpert, histo pathological examination
and mycobacterial culture and drug susceptibility testing.
Statistical analysis
The data was entered in Excel and analysed in STATA 16. Descriptive
statistics was used to summarise the individual characteristics.
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DATA ANALYSIS AND RESULTS
From Dec 2014 to August 2015, total of 50 patients were recruited. Among
them, 40% were males and60% were females. The mean age of the participants
was 33.5 years (95% CI: 29.2-37.9). The mean age among females was 29.8 years
(95% CI: 25-34.5) and the mean age among males was 39.1 years (95% CI: 31.4-
46.9). The figure below shows the age distribution among male and female
participants.
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With histo pathological examination, 31 (62%) patients had histo
pathological changes suggestive of TB. Malignant changes were seen in 6 (12%)
patients. Non specific reactive lymphadenitis was seen in 13 (26%) patients. The
figure below shows the different histology changes reported in the participants.
HPE_malinancy HPE_reactive
tb_positive
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The table below shows the sex distribution with histo pathological changes in the
lymph nodes.
Index Frequency
TB_positive
Female 22
Male 9
HPE_Malignancy
Female 3
Male 3
HPE_Reactive
Node
Female 5
Male 8
The distribution of lymph node enlargement among the patients is as
follows.The cervical lymph node enlargement was seen in majority of patients
(83.87%), followed by submandibular lymph nodes (6.45%), axillary nodes
(6.45%) and supra clavicular nodes (3.23%).
TB Positive FREQUENCY PERCENTAGE
SUB MANDIBULAR 2 6.45
SUPRA-CLAVICULAR 1 3.23
AXLLARY 2 6.45
CERVICAL 26 83.87
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Among the 50 participants, 26 patients were positive for Mycobacterial
culture for tuberculosis, 16 patients positive for M.tuberculosis with GeneXpert
and 31 patients positive in histo pathological examination. GeneXpert and culture
was both positive for M.TB in 13 patients. HPE and culture was positive in 23
patients. HPE and geneXpert was positive for M.TB in 17 patients. The table
below summarises the results positive for M.TB in HPE, AFB culture and
geneXpert.
TB POSITIVE
Culture for AFB positive 26
Gene expert positive 17
Gene expert & AFB culture positive 13
HPE TB ADENITIS 31
HPE & AFB CULTURE POSITIVE 26
HPE & GENE EXPERT 16
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The odds ratio was calculated for HPE, AFB culture and sensitivity and
GeneXpert test by Fisher Exact test.
Fisher exact test for HPE and GeneXpert
Odds ratio was calculated for diagnosis of TB by GeneXpert compared to
HPE. had 3.8 times more chances of diagnosing TB adenitis than GeneXpert with
P-value of 0.001.
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Fisher exact test for AFB culture and sensitivity and GeneXpert
Odds ratio was calculated for diagnosis of TB by GeneXpert compared to
AFB culture and sensitivity. AFB culture and sensitivity had 2.1 times more
chances of diagnosing TB adenitis than GeneXpert with P-value of 0.018.
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DISCUSSION & CONCLUSION
This study describes the etiological causes of lymphadenopathy in patients
attending tertiary care centre among south Indian population. The following were
the results of the study
a. Among the study participants, 60% were females and they
presented at younger age compared to males.
b. Histo pathological changes suggestive of TB was seen in 62% of
the subjects.
c. Malignant changes were seen in 12% of the subjects.
d. Non specific reactive lymph adenitis was seen in 26% of patients.
e. The most common site of lymphadenopathy was cervical region
f. Among patients diagnosed with TB lymphadenitis, 71% were
females.
g. All the 31 patients diagnosed with TB lymphadenitis were
positive for M.TB in histo-pathological examination.
h. 17 samples were positive with GeneXpert and 26 samples were
positive for AFB culture.
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i. AFB culture and sensitivity when compared to GeneXpert had 2.1
times more chances of detecting TB adenitis.
j. HPE for TB adenitis when compared to GeneXpert had 3.8 times
more chances of detecting TB adenitis.
The fact that TB lymphadenitis is more common among females is
supported by other studies done by Kulkarni and Frimodt Moller 1969,
Krishnaswami et al 1972 and Pamra 1974.
Cervical region is the most common site of lymphadenopathy in
this study which is also established in other studies by Doctor 1964, Frase
1965 and Kent 1967. More evidence is needed to establish the role of
GeneXpert in diagnosis of lymph node tuberculosis.
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PATIENT PROFORMA
PATIENT DETAILS:
Name: Age: Sex:
IP No. :
Smoker
Alcohol
District
State
Married
Occupation
Socio-economic status.
Education
ON ADMISSION:
Main Complaints :
Duration of Complaints :
Co – Morbid Illness :
Significant Past History :
CLINICAL EXAMINATION:
Pulse : BP :
RR : Temp :
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Pallor : Icterus :
CVS :
RS :
P/A :
INVESTIGATIONS :
CBC : ESR :
Liver Function Test :
Renal Function Test :
CXR :
USG Abdomen
USG neck
HIV screening
Biopsy & HPE
AFB culture
GeneXpert
TREATMENT :
Intra – op Findings.
FOLLOW UP :
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MASTER CHART
id_no Sex Age ip_no HIV_positive previous_ATT on_ATT lymph_node
1 1 34 14131 1 1 0 1
2 0 25 16505 0 0 0 1
3 1 46 16430 0 0 0 1
4 1 33 16492 0 0 0 1
5 0 28 52943 0 0 0 1
6 0 19 52944 0 0 0 1
7 1 29 60102 0 0 0 1
8 0 50 59518 0 0 0 1
9 0 30 64058 0 0 0 1
10 0 19 64306 0 0 0 1
11 0 20 66023 0 0 0 1
12 0 25 67075 0 0 0 1
13 0 60 68684 0 0 0 1
14 0 27 69742 0 0 0 1
15 0 22 69814 0 1 0 1
16 0 45 67102 1 1 0 1
17 1 77 69933 0 0 0 1
18 0 22 69182 0 0 0 1
19 0 31 69723 0 0 0 1
20 1 29 229360 0 0 0 1
21 0 70 25366 0 0 0 1
22 0 26 64522 0 0 0 1
23 0 39 82891 0 1 0 1
24 1 21 81446 0 0 0 1
25 0 21 86915 0 0 0 1
26 0 19 87575 0 0 0 1
27 0 22 86375 0 1 0 1
28 0 38 87627 1 0 0 1
29 1 59 89577 0 0 0 1
30 1 37 90337 0 0 0 1
31 0 27 89455 0 0 0 1
32 0 19 85709 0 0 0 1
33 1 34 66734 0 0 1 1
34 0 28 89927 0 1 0 1
35 0 42 17129 0 0 0 1
36 1 37 89892 0 0 0 1
37 1 52 90929 0 0 0 1
38 0 19 10102 0 0 0 1
39 1 46 116413 0 0 0 1
40 1 33 11129 0 0 0 1
41 1 19 76729 0 0 1 1
42 0 19 92993 0 0 0 1
43 1 27 109742 0 0 0 1
44 0 22 10112 0 1 0 1
45 1 82 16993 0 0 0 1
46 1 32 122936 0 0 1 1
47 1 19 18691 0 0 0 1
48 0 38 187627 0 1 0 1
49 1 37 90338 0 0 0 1
50 0 22 186317 0 0 0 1
cervical_node axillary_node supra_clavicular_node sub_mandibular_node cold_abscess
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
0 1 0 0 0
1 0 0 0 0
0 1 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
0 1 0 0 0
1 0 0 0 0
0 0 0 1 0
1 0 0 0 0
0 0 1 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
0 0 0 1 0
0 1 0 0 0
1 0 0 0 0
1 0 0 0 0
0 0 1 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
0 0 1 0 0
1 0 0 0 0
1 0 0 0 0
1 0 0 0 0
0 0 1 0 1
1 0 0 0 0
HPE_TB HPE_malinancy HPE_reactive Gene_expert_positive AFB_c/s tb_positive
0 0 1 0 0 0
0 0 1 0 0 0
1 0 0 1 1 1
0 0 1 0 0 0
1 0 0 0 1 1
1 0 0 1 1 1
1 0 0 0 0 1
0 1 0 0 0 0
1 0 0 1 1 1
1 0 0 1 1 1
1 0 0 0 0 1
0 0 1 0 0 0
0 1 0 0 0 0
1 0 0 1 1 1
1 0 0 1 1 1
1 0 0 0 1 1
0 1 0 0 0 0
0 0 1 0 0 0
1 0 0 0 1 1
0 0 1 0 0 0
0 0 1 0 0 0
1 0 0 1 0 1
1 0 0 1 1 1
0 1 0 0 0 0
1 0 0 1 0 1
1 0 0 1 0 1
1 1 0 0 1 1
1 0 0 0 1 1
0 0 1 0 0 0
1 0 0 0 1 1
1 0 0 1 1 1
1 0 0 0 1 1
1 0 1 1 1 1
1 0 0 0 1 1
1 0 0 1 1 1
0 0 1 0 0 0
0 0 1 0 0 0
1 0 0 1 1 1
1 0 0 1 1 1
1 0 0 0 1 1
0 1 0 0 0 0
1 0 0 0 1 1
1 0 0 0 1 1
0 0 1 0 0 0
0 0 1 0 0 0
1 0 0 0 1 1
0 0 0 1 0 0
1 0 0 1 1 1
1 0 0 0 1 1
0 0 0 0 0 0
